AlphaQuest LLC Trims Stake in Encompass Health Corporation $EHC

Key Points

• AlphaQuest LLC reduced its stake in Encompass Health Corporation by 53.0%, holding 13,496 shares after selling 15,204 shares, which are valued at approximately $1,367,000.
• Encompass Health recently reported a quarterly earnings per share of $1.40, exceeding estimates and representing a 12.0% increase in revenue year-over-year.
• The company announced an increase in its quarterly dividend from $0.17 to $0.19 per share, with the new dividend set to be paid on October 15th.

AlphaQuest LLC decreased its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 53.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,496 shares of the company's stock after selling 15,204 shares during the quarter. AlphaQuest LLC's holdings in Encompass Health were worth $1,367,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in EHC. Colonial Trust Co SC purchased a new stake in shares of Encompass Health in the 4th quarter worth approximately $29,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock worth $42,000 after buying an additional 367 shares during the period. Arlington Trust Co LLC boosted its position in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Encompass Health in the 4th quarter valued at $72,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after acquiring an additional 115 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. UBS Group raised their target price on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, KeyCorp raised their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $134.00.

Encompass Health Stock Down 0.5%

Shares of EHC stock opened at $122.76 on Friday. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $124.67. The firm has a market capitalization of $12.36 billion, a PE ratio of 24.02, a P/E/G ratio of 2.16 and a beta of 0.86. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The stock's 50-day simple moving average is $116.38 and its 200-day simple moving average is $110.27.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the company earned $1.11 EPS. Encompass Health's quarterly revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio (DPR) is currently 14.87%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.